China Pharma Holdings Inc (CPHI) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
China Pharma Holdings Inc  (NYSEAMER: CPHI)


China Pharma Holdings Inc's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CPHI Gross Profit Margin (Jun 30 2026)
Q2 		(Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3 		(Jun 30 2025)
Q2
Y / Y Revenue Change -7.55 %
Seq. Revenue Change -3.58 %
Revenue In Millions $0.95
Gross Profit Margin 8.81 %
Gross Profit Margin Total Ranking # 2544
Gross Profit In Millions $0.08
Y / Y Gross Profit Change -
Seq. Gross Profit Change -70.73 %


Commenting Second Quarter 2026 Gross Profit Margin
China Pharma Holdings Inc experienced contraction in Gross Profit by -70.73 % to $1 millions and Revenue by -3.58 %, while Gross Profit Margin fell to 8.81 %, below company*s average Gross Profit Margin.


Observing second quarter 2026 results within Major Pharmaceutical Preparations industry 130 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2544, from total ranking in the previous quarter at 3451.
Learn about Gross Margin
CPHI's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 131
Healthcare Sector # 391
Overall # 2524

Gross Profit Margin Statistics
High Average Low
72.13 % 19.82 % 1.46 %
(Dec 31 2015)   (Dec 31 2022)


CPHI Gross Income Trends • More of CPHI's Profitabilty Ratios • CPHI Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
CPHI's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CPHI's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CPHI's Competitors
Gross Profit Margin Profit Margin for China Pharma Holdings Inc's Suppliers
Gross Profit Margin Profit Margin for CPHI's Customers

You may also want to know
CPHI's Annual Growth Rates CPHI's Profitability Ratios CPHI's Asset Turnover Ratio CPHI's Dividend Growth
CPHI's Roe CPHI's Valuation Ratios CPHI's Financial Strength Ratios CPHI's Gross Profit Growth
CPHI's Roa CPHI's Inventory Turnover Ratio CPHI's Growth Rates CPHI's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
Prophase Labs Inc   22.35 %$ 0.226  Millions$ 1.011  Millions
Pmgc Holdings Inc   21.01 %$ 0.274  Millions$ 1.307  Millions
Aspire Biopharma Holdings Inc   19.47 %$ 0.012  Millions$ 0.063  Millions
Rockwell Medical inc   18.24 %$ 3.243  Millions$ 17.780  Millions
Igc Pharma Inc   18.11 %$ 0.048  Millions$ 0.265  Millions
Jaguar Health Inc   15.84 %$ 0.194  Millions$ 1.225  Millions
Hcw Biologics Inc   10.82 %$ 0.028  Millions$ 0.257  Millions
China Pharma Holdings Inc  8.81 %$ 0.084  Millions$ 0.948  Millions
Lftd Partners Inc   7.48 %$ 0.651  Millions$ 8.705  Millions
Biora Therapeutics Inc   6.27 %$ 0.202  Millions$ 3.215  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.